The Effect of Infrared Light Use in Oncology Patients Receiving Chemotherapy

Launched by ULUDAG UNIVERSITY · May 29, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how infrared light can help reduce fear and pain during a specific procedure called a Peripheral Intravenous Catheter (PIVC) insertion in cancer patients receiving chemotherapy. The goal is to see if using infrared light can make this procedure more comfortable and improve patient satisfaction. Participants will be divided into different groups to compare the effects of infrared light, a different imaging method, and a control group that does not use these methods.

To be eligible for this study, participants should be between 18 and 74 years old, have received chemotherapy treatment, and not have any allergies or certain health conditions that could interfere with the study. Those who are participating can expect to be involved in a randomized trial, meaning they may be assigned to different treatment groups by chance. It’s important to note that this study is not currently recruiting participants, so interested individuals should keep an eye out for when it starts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients who have undergone chemotherapy treatment and have received their first cure,
• • patients between the ages of 18 and 74,
• • patients who have not allergic to any substance,
• • patients who no peripheral vascular disease,
• • patients who does not have a chronic disease diagnosed other than cancer,
• • patients who does not use alcohol,
• • patients who non-smoker,
• • patients who not taking anticoagulant treatment,
• • patients who no signs of infiltration and phlebitis,
• • patients who have not acute trauma around the extremity, inflammation, ecchymosis, hematoma, scar tissue, edema, metal prosthesis, no paralysis,
• • patients who no visible deformity and thrombocytopenia in the examination,
• • patient who mastectomy has not been performed,
• • patients who do not have communication problems and whose mental level is suitable to participate in the research will be taken.
• Exclusion Criteria:
• • patients who have under the age of 18 and over the age of 74,
• • patients who will receive chemotherapy for the first time,
• • patients who changing chemotherapy cure treatment,
• • patients who allergic to any substance,
• • patients who do not volunteer to participate in the study will not be included in the study.